Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?

Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · see citing works

The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530 · see citing works

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,488 · see citing works

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · see citing works

Rosmarinic acid

Petersen, M. (2002) · Phytochemistry · doi:10.1016/s0031-9422(02)00513-7 · Cited by 1,265 · see citing works

Nitric Oxide Scavenging by Curcuminoids

Sreejayan, & Rao, M. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06761.x · Cited by 1,138 · see citing works

Oxidative stress in Alzheimer’s disease

Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00040-5 · Cited by 895 · see citing works

Review: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity

Varadarajan, S., Yatin, S., Aksenova, M., & Butterfield, D. A. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4274 · Cited by 735 · see citing works

Expression of Concern: Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01976.x · Cited by 681 · see citing works

Vitamin E protects nerve cells from amyloid βprotein toxicity

Behl, C., Davis, J. B., Cole, G. M., & Schubert, D. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90837-b · Cited by 582 · see citing works

Kinetic theory of fibrillogenesis of amyloid β-protein

Lomakin, A., Teplow, D. B., Kirschner, D. A., & Benedek, G. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7942 · Cited by 529 · see citing works

Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents

Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Malone, W. A., Boone, C. W., Kopelovich, L., Hawk, E. T., Lieberman, R., Lawrence, J. A., et al. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.467s · Cited by 441 · see citing works

Inhibition of Alzheimer's Amyloidosis by Peptides That Prevent β-Sheet Conformation

Soto, C. A., Kindy, M. S., Baumann, M., & Frangione, B. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1413 · Cited by 432 · see citing works

In Vivo Inhibition of Nitric Oxide Synthase Gene Expression by Curcumin, a Cancer Preventive Natural Product with Anti-Inflammatory Properties

Chan, M. M.-Y., Huang, H., Fenton, M. R., & Fong, D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00114-2 · Cited by 398 · see citing works

Oxidative injury in diseases of the central nervous system: focus on alzheimer’s disease

Praticò, D., & Delanty, N. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00547-7 · Cited by 378 · see citing works

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 360 · see citing works

The Relation Between Antioxidants and Memory Performance in the Old and Very Old

Perrig, W. J., Perrig, P., & Stähelin, H. B. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb01476.x · Cited by 344 · see citing works

Inhibition of Alzheimer β-Fibrillogenesis by Melatonin

Pappolla, M. A., Bozner, P., Soto, C. A., Shao, H., Robakis, N. K., Zagorski, M. G., Frangione, B., & Ghiso, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7185 · Cited by 338 · see citing works

Apolipoprotein E Polymorphism and Alzheimer Disease

Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandav, R. S., Belle, S. H., & DeKosky, S. T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.824 · Cited by 337 · see citing works

Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals

Zhao, B., Li, X., He, R., Cheng, S., & Wenjuan, X. (1989) · Cell Biophysics · doi:10.1007/bf02797132 · Cited by 322 · see citing works

Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity

Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., & Akaike, A. (1997) · Annals of Neurology · doi:10.1002/ana.410420205 · Cited by 315 · see citing works

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin

Tomiyama, T., Shoji, A., Kataoka, K.-I., Suwa, Y., Asano, S., Kaneko, H., & Endo, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6839 · Cited by 295 · see citing works

[20] Kinetic analysis of amyloid fibril formation

Naiki, H., & Gejyo, F. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09022-9 · Cited by 287 · see citing works

Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells

Zhang, F., Altorki, N. K., MESTRE, J. R., Subbaramaiah, K., & Dannenberg, A. J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.445 · Cited by 287 · see citing works

Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA(1–42) insult

Kim, D. S. H. L., Park, S., & Kim, J.-Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01677-9 · Cited by 262 · see citing works

Dietary Antioxidants and Cognitive Function in a Population-based Sample of Older Persons: The Rotterdam Study

Jama, J. W., Launer, L. J., Witteman, J. C. M., den Breeijen, J. H., Breteler, M. M. B., Grobbee, D. E., & Hofman, A. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008922 · Cited by 252 · see citing works

First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.

Naiki, H., & Nakakuki, K. (1996) · PubMed · Cited by 244 · see citing works

Anti‐amyloidogenic activity of tetracyclines: studies in vitro

Forloni, G., Colombo, L., Girola, L., Tagliavini, F., & Salmona, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02380-2 · Cited by 242 · see citing works

Interaction between Aβ(1−42) and Aβ(1−40) in Alzheimer's β-Amyloid Fibril Formation in Vitro

Hasegawa, K., Yamaguchi, I., Omata, S., Gejyo, F., & Naiki, H. (1999) · Biochemistry · doi:10.1021/bi991161m · Cited by 217 · see citing works

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation

Goodman, Y., Steiner, M. R., Steiner, S. M., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91586-5 · Cited by 202 · see citing works

Strategy and planning for chemopreventive drug development: Clinical development plans II

Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630705 · Cited by 196 · see citing works

Antioxidant strategies for Alzheimer's disease

Grundman, M., & Delaney, P. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002146 · Cited by 193 · see citing works

Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in Vitro

Tomiyama, T., Asano, S., Suwa, Y., Morita, T., Kataoka, K., Mori, H., & Endo, N. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2428 · Cited by 158 · see citing works

Involvement of Oxidative Stress on the Impairment of Energy Metabolism Induced by Aβ Peptides on PC12 Cells: Protection by Antioxidants

Pereira, C., Santos, M. S., & Oliveira, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0241 · Cited by 156 · see citing works

Evidence for caspase‐mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease

Chan, S. L., Griffin, W. S. T., & Mattson, M. P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990801)57:3 · Cited by 137 · see citing works

Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells.

Xu, Y. X., Pindolia, K. R., Janakiraman, N., Chapman, R. A., & Gautam, S. C. (1997) · PubMed · Cited by 123 · see citing works

Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer's β‐amyloid fibrils in vitro

Ono, K., Hasegawa, K., Yoshiike, Y., Takashima, A., Yamada, M., & Naiki, H. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00904.x · Cited by 121 · see citing works

Apolipoprotein E and Antioxidants Have Different Mechanisms of Inhibiting Alzheimer's β-Amyloid Fibril Formation in Vitro

Naiki, H., Hasegawa, K., Yamaguchi, I., Nakamura, H., Gejyo, F., & Nakakuki, K. (1998) · Biochemistry · doi:10.1021/bi980550y · Cited by 120 · see citing works

Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin

Caughey, B. W., Raymond, L. D., Raymond, G. J., Maxson, L., Silveira, J. R., & Baron, G. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5499-5502.2003 · Cited by 119 · see citing works

Kinetic Modeling and Determination of Reaction Constants of Alzheimer's β-Amyloid Fibril Extension and Dissociation Using Surface Plasmon Resonance

Hasegawa, K., Ono, K., Yamada, M., & Naiki, H. (2002) · Biochemistry · doi:10.1021/bi020369w · Cited by 117 · see citing works

Nicotine breaks down preformed Alzheimer’s β-amyloid fibrils in vitro

Ono, K., Hasegawa, K., Yamada, M., & Naiki, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01417-8 · Cited by 116 · see citing works

Concentration-Dependent Inhibitory Effects of Apolipoprotein E on Alzheimer's β-Amyloid Fibril Formation in Vitro

Naiki, H., Gejyo, F., & Nakakuki, K. (1997) · Biochemistry · doi:10.1021/bi9624705 · Cited by 103 · see citing works

Rosmarinic acid

Parnham, M. J., & Kesselring, K. (1985) · Drugs of the Future · doi:10.1358/dof.1985.010.09.71743 · Cited by 102 · see citing works

The Free Radical Antioxidant Vitamin E Protects Cortical Synaptosomal Membranes from Amyloid β-Peptide(25-35) Toxicity But Not from Hydroxynonenal Toxicity: Relevance to the Free Radical Hypothesis of Alzheimer's Disease

Subramaniam, R., Koppal, T., Green, M., Yatin, S. M., Jordan, B., Drake, J., & Butterfield, D. A. (1998) · Neurochemical Research · doi:10.1023/a:1020754807671 · Cited by 100 · see citing works

Oxidative Stress, Antioxidants, and Alzheimer Disease

Rottkamp, C. A., Nunomura, A., Raina, A. K., Sayre, L. M., Perry, G. L., & Smith, M. A. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00010 · Cited by 100 · see citing works

Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E

Yatin, S. M., Yatin, M., Aulick, T., Ain, K. B., & Butterfield, D. A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00101-9 · Cited by 96 · see citing works

Pharmacological treatment of Alzheimer disease: From psychotropic drugs and cholinesterase inhibitors to pharmacogenomics

Cacabelos, R., Álvarez, A., Lombardi, V., & al., E. (2000) · Drugs of today · doi:10.1358/dot.2000.36.7.589153 · Cited by 82 · see citing works

Actions of Neurotoxic β‐Amyloid on Calcium Homeostasis and Viability of PC12 Cells Are Blocked by Antioxidants but Not by Calcium Channel Antagonists

Zhou, Y., Gopalakrishnan, V., & Richardson, J. S. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041419.x · Cited by 81 · see citing works

Modifications on Antioxidant Capacity and Lipid Peroxidation in Mice under Fraxetin Treatment

Martín‐Aragón, S., Benedı́, J., & Villar, Á. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06751.x · Cited by 78 · see citing works

Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata)

Luo, J., Chuang, T., Cheung, J., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00139-3 · Cited by 78 · see citing works

Nicotine and amyloid formation

Zeng, H., Zhang, Y., Peng, L., Shao, H., Menon, N. K., Yang, J., Salomon, A. R., Freidland, R. P., & Zagorski, M. G. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01111-2 · Cited by 72 · see citing works

Phytoestrogen kaempferol (3,4',5,7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity.

Roth, A. B., Schaffner, W., & Hertel, C. (1999) · PubMed · Cited by 66 · see citing works

Effects of catechins on human blood platelet aggregation and lipid peroxidation

Neiva, T. J. C., de Morais, L. C. S. L., Polack, M., Simões, C. M. O., & D’Amico, É. A. (1999) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199911)13:7 · Cited by 44 · see citing works

Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats

Kaul, S., & Krishnakantha, T. P. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006829010327 · Cited by 37 · see citing works

β-Secretase revealed: starting gate for race to novel therapies for Alzheimer’s disease

Skovronsky, D., & Lee, V. M. ‐. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01467-x · Cited by 27 · see citing works

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works

Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery

Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270 · see citing works

The effect of curcumin (turmeric) on Alzheimer’s disease: An overview

Mishra, S., & Palanivelu, K. (2008) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.40220 · Cited by 599 · see citing works

REVIEW: Curcumin and Alzheimer’s disease

Hamaguchi, T., Ono, K., & Yamada, M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00147.x · Cited by 450 · see citing works

Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population

Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368 · see citing works

Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer’s Disease

Reddy, P. H., Manczak, M., Yin, X., Grady, M. C., Mitchell, A., Tonk, S., Kuruva, C. S., Bhatti, J. S., Kandimalla, R., Vijayan, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170512 · Cited by 354 · see citing works

Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease

Ahmed, T., & Gilani, A.-H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.010 · Cited by 301 · see citing works

Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment

Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.09.030 · Cited by 289 · see citing works

Neuroprotective effect of natural products against Alzheimer’s disease

Essa, M. M., Vijayan, R. K., Castellano-Gonzalez, G., Memon, M. A., Braidy, N., & Guillemin, G. J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0799-9 · Cited by 278 · see citing works

Nanoemulsions for “Nose-to-Brain” Drug Delivery

Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269 · see citing works

Multifunctional Nanoliposomes with Curcumin-Lipid Derivative and Brain Targeting Functionality with Potential Applications for Alzheimer Disease

Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263 · see citing works

Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT)

Ishrat, T., Hoda, M. N., Khan, M. B., Yousuf, S., Ahmad, M., Khan, M. M., Ahmad, A., & Islam, F. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.002 · Cited by 230 · see citing works

Neurotherapeutic applications of nanoparticles in Alzheimer’s disease

Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219 · see citing works

Clinical development of curcumin in neurodegenerative disease

Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179 · see citing works

Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer’s disease

Ahmed, T., Enam, S. A., & Gilani, A. H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.078 · Cited by 156 · see citing works

Effect of Curcumin-Associated and Lipid Ligand-Functionalized Nanoliposomes on Aggregation of the Alzheimer's Aβ Peptide

Taylor, M., Moore, S., Mourtas, S., Niarakis, A., Re, F., Zona, C., Ferla, B. L., Nicotra, F., Masserini, M., Antimisiaris, S. G., et al. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.06.015 · Cited by 149 · see citing works

Can herbs provide a new generation of drugs for treating Alzheimer’s disease?

Anekonda, T. S., & Reddy, P. H. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.09.001 · Cited by 140 · see citing works

Alzheimer’s disease as oligomeropathy

Ono, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.010 · Cited by 129 · see citing works

The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease

Divino da Rocha, M., Pereira Dias Viegas, F., Cristina Campos, H., Carolina Nicastro, P., Calve Fossaluzza, P., Alberto Manssour Fraga, C., J. Barreiro, E., & Viegas, C. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480429 · Cited by 126 · see citing works

Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease

Amato, A., Terzo, S., & Mulè, F. (2019) · Antioxidants · doi:10.3390/antiox8120608 · Cited by 107 · see citing works

Nutrition and AGE‐ing: Focusing on Alzheimer’s Disease

Abate, G., Marziano, M., Rungratanawanich, W., Memo, M., & Uberti, D. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7039816 · Cited by 103 · see citing works

Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities

Yan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5288698 · Cited by 97 · see citing works

Neuroprotective effects of Bacopa monnieri in experimental model of dementia

Saini, N., Singh, D., & Sandhir, R. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0811-4 · Cited by 95 · see citing works

New Insights in Amyloid Beta Interactions with Human Telomerase

Wang, J., Zhao, C., Zhao, A., Li, M., Ren, J., & Qu, X. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511030s · Cited by 90 · see citing works

Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease

Parachikova, A., Green, K. N., Hendrix, C., & LaFerla, F. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014015 · Cited by 87 · see citing works

Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow

Awasthi, H., Tota, S., Hanif, K., Nath, C., & Shukla, R. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.007 · Cited by 86 · see citing works

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works

Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.

Tramutola, A., Lanzillotta, C., & Di Domenico, F. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1244482 · Cited by 69 · see citing works

Phytotherapy: A promising approach for the treatment of Alzheimer's disease

John, O. O., Amarachi, I. S., Chinazom, A. P., Adaeze, E., Kale, M. B., Umare, M. D., & Upaganlawar, A. B. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100030 · Cited by 69 · see citing works

Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions

Walker, D., & Lue, L.-F. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793667 · Cited by 66 · see citing works

Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites

Frausto, D. M., Forsyth, C. B., Keshavarzian, A., & Voigt, R. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736814 · Cited by 61 · see citing works

Enhanced detection and retrograde axonal transport of PrP^c in peripheral nerve

Moya, K. L., Hässig, R., Créminon, C., Laffont, I., & Di Giamberardino, L. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02150.x · Cited by 58 · see citing works

Phenotypic variability in human prion diseases

Ironside, J. W., Ritchie, D. L., & Head, M. W. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00697.x · Cited by 58 · see citing works

Rescuing apoptotic neurons in Alzheimer’s disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin

Kuo, Y.-C., & Lin, C.-C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79528 · Cited by 56 · see citing works

Recent Development of Bifunctional Small Molecules to Study Metal‐Amyloid‐<i>β</i> Species in Alzheimer′s Disease

Braymer, J. J., DeToma, A. S., Choi, J.-S., Ko, K. S., & Lim, M. H. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/623051 · Cited by 50 · see citing works

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47 · see citing works

Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease

Adalier, N., & Parker, H. (2016) · Antioxidants · doi:10.3390/antiox5040040 · Cited by 40 · see citing works

Protective and anti-oxidative effects of curcumin and resveratrol on Aβ-oligomer-induced damage in the SH-SY5Y cell line

Yu, H., Yamashita, T., Hu, X., Bian, Z., Hu, X., Feng, T., Tadokoro, K., Morihara, R., & Abe, K. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120356 · Cited by 37 · see citing works

Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells

Lobine, D., Sadeer, N., Jugreet, S., Suroowan, S., Keenoo, B. S., Imran, M., Venugopala, K. N., Ibrahim, F. M., Zengin, G., & Mahomoodally, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210412095251 · Cited by 32 · see citing works

Linear quantitation of Aβ aggregation using Thioflavin T: Reduction in fibril formation by colostrinin

Bourhim, M., Kruzel, M. L., Srikrishnan, T., et al. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.09.013 · Cited by 49 · see citing works

Structural Analogue of Thioflavin T, DMASEBT, as a Tool for Amyloid Fibrils Study

Sulatskaya, A. I., Sulatsky, M. I., Antifeeva, I. A., Kuznetsova, I. М., & Константинович, Т. К. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05737 · Cited by 23 · see citing works

Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association.

Moss, M. A., Varvel, N. H., Nichols, M. R., Reed, D. K., & Rosenberry, T. L. (2004) · PubMed · doi:10.1124/mol.66.3 · Cited by 37 · see citing works

Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Dickson, D. W., Farlo, J., Davies, P., Crystal, H., Fuld, P. A., & Yen, S. H. (1988) · PubMed Central · Cited by 383 · see citing works

Variable Binding of Thioflavin T to Amyloid Fibrils

Komatsu, H., Meurice, C., & Axelsen, P. H. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2018.11.1079